115480.Kq
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a relatively strong liquidity position, with a current ratio of 4.84, indicating that it has sufficient current assets to cover its current liabilities. However, its liquidity risk is assessed as medium, likely due to the negative net cash position after subtracting total debt. The company holds cash and equivalents of 18,555,746,120 KRW, but this is offset by long-term debt of 33,394,714,000 KRW, resulting in a net cash outflow.
Profitability metrics show a return on equity (ROE) of 1.37% and a return on assets (ROA) of 0.82%, both of which are below the typical thresholds for strong performance in the healthcare equipment and supplies industry. The company's operating income of 10,813,118,960 KRW and net income of 819,203,810 KRW suggest modest profitability, with a gross profit margin of 59.1%.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided. This lack of diversification may expose the company to higher operational and market risks if the segment faces challenges.
The company's growth trajectory is not clearly defined in the available data, as no specific revenue growth rates or future projections are provided. However, the capital expenditure of -776,173,900 KRW suggests a reduction in investment in physical assets, which may indicate a focus on cost optimization or a slowdown in expansion.
The risk assessment indicates a low potential for dilution, with no significant dilution sources identified in the available documents. The company's debt-to-equity ratio of 0.56 suggests a moderate level of leverage, and the risk of dilution is further supported by the absence of recent equity issuance or convertible instruments.
No recent events, such as filings or transcripts, are provided in the available data to indicate any material changes in the company's operations or strategic direction. The absence of such information suggests a stable but potentially less dynamic business environment.
- The company has a strong current ratio of 4.84, indicating good short-term liquidity.
- Profitability is modest, with ROE and ROA below typical industry benchmarks.
- The company's revenue is concentrated in a single business segment, increasing operational risk.
- The company has a moderate debt-to-equity ratio of 0.56, suggesting a balanced capital structure.
- No significant dilution sources are identified, and the risk of dilution is assessed as low.
- The company's capital expenditure is negative, indicating a reduction in investment in physical assets.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 115480.KQ Market data — financials · 2026-05-26